Glaxosmithkline Pharmaceuticals Limited (GLAXO)
ISIN: - Industry: Drug Manufacturers—General Sector: Healthcare Website
1522.3
-2.7(-0.18%)

GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for anti-infective, gastrointestinal, nutrition, dermatology, respiratory, and rare diseases; and consumer healthcare products. It provides its product under the Augmentin, Betnovate, Calpol, Ceftum, and Synflorix brands. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.

Pricing Updates

TODAY'S HIGH

1529.95

TODAY'S LOW

1503.3

52 WEEK HIGH

1918.75

52 WEEK LOW

1449

Major Holders

% of Shares Held by
All Insider

75.54%

% of Shares Held by
Institutions

11.94%

% of Float Held by
Institutions

48.81%

Number of Institutions
Holding Shares

46

Company Overview

MARKET CAP

25788.67 Cr.

ETERPRISE VALUE

25438.46 Cr.

NO. OF SHARES

16.94 Cr.

BOOK VALUE

76.491

DIV. YIELD

60%

DEBT

27.61 Cr.

GROSS PROFIT

1864.66 Cr.

CASH

1189.07 Cr.

REVENUE

3486.09 Cr.

REVENUE/SHARE

205.757

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Investments225 Cr.92 Cr.20 Cr.-332.50 Cr.
Change To Liabilities107.40 Cr.-48.22 Cr.-100.04 Cr.226.92 Cr.
Total cashflows from Investing Activities418.59 Cr.-56.84 Cr.-153.45 Cr.-104.19 Cr.
Net Borrowings-14.98 Cr.-15.05 Cr.-40.60 Lakhs-60.60 Lakhs
Total Cash from Financing Activities-696.13 Cr.-427.62 Cr.-358.35 Cr.-306.63 Cr.
Other Liabilities85.07 Cr.160.06 Cr.55.26 Cr.-11.14 Cr.
Total Assets0000
Net Income358.14 Cr.93.20 Cr.445.39 Cr.350.72 Cr.
Change in Cash300.37 Cr.6.03 Cr.-102.32 Cr.61.97 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities577.92 Cr.490.49 Cr.409.48 Cr.472.79 Cr.
Depreciation70.25 Cr.72.89 Cr.38.83 Cr.34.09 Cr.
Other Cashflows from Investing Activities55.30 Cr.3.55 Cr.69.78 Cr.79.22 Cr.
Dividends Paid-677.62 Cr.-338.81 Cr.-296.46 Cr.-254.10 Cr.
Change to Inventory-46.79 Cr.-67.71 Cr.13.68 Cr.-74.38 Cr.
Change to Account Receivables-99.93 Cr.-4.97 Lakhs26.89 Cr.23.16 Cr.
Other Cashflows from Financing Activities-3.53 Cr.-73.75 Cr.-61.49 Cr.-51.91 Cr.
Change to Net Income94.73 Cr.270.54 Cr.-80.30 Cr.-80.47 Cr.
Capital Expenditures-44.22 Cr.-155.89 Cr.-291.28 Cr.-403.38 Cr.

Financials

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax550.49 Cr.305.75 Cr.682.66 Cr.539.96 Cr.
Minority InterestNoneNoneNoneNone
Net Income616.10 Cr.586.93 Cr.557.06 Cr.477.21 Cr.
Selling General Administrative747.05 Cr.774.14 Cr.692.54 Cr.640.23 Cr.
Gross Profit1864.66 Cr.1899.37 Cr.1749.27 Cr.1612.24 Cr.
Ebit616.10 Cr.586.93 Cr.557.06 Cr.477.21 Cr.
Operating Income616.10 Cr.586.93 Cr.557.06 Cr.477.21 Cr.
Other Operating Expenses422.40 Cr.455.98 Cr.451.64 Cr.456.81 Cr.
Interest Expense-3.53 Cr.-6.33 Cr.-55.43 Lakhs-18.91 Lakhs
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense192.35 Cr.212.54 Cr.237.27 Cr.189.23 Cr.
Total Revenue3198.86 Cr.3224.38 Cr.3128.11 Cr.2871.45 Cr.
Total Operating Expenses2582.75 Cr.2637.44 Cr.2571.05 Cr.2394.23 Cr.
Cost of Revenue1334.19 Cr.1325 Cr.1378.84 Cr.1259.21 Cr.
Total Other Income Expense Net-65.60 Cr.-281.18 Cr.125.60 Cr.62.75 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.358.14 Cr.93.20 Cr.445.39 Cr.350.72 Cr.
Net Income Applicable to Common Shares358.14 Cr.93.20 Cr.445.39 Cr.350.72 Cr.

Balance Sheet

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Intangible Assets43.36 Cr.49.62 Cr.65.54 Cr.72.68 Cr.
Capital Surplus0000
Total Liabilities1614.28 Cr.1312.62 Cr.1771.48 Cr.1890.15 Cr.
Stock Holder Equity1499.07 Cr.1820.60 Cr.2139.82 Cr.2057.32 Cr.
Minority Interest0000
Other Liabilities647.04 Cr.496.61 Cr.904.03 Cr.966.85 Cr.
Total Assets3113.36 Cr.3133.23 Cr.3911.31 Cr.3947.48 Cr.
Common Stock169.40 Cr.169.40 Cr.169.40 Cr.84.70 Cr.
Retained Earnings1334.54 Cr.1654.02 Cr.1969.27 Cr.1965.98 Cr.
Other Liabilities261.55 Cr.263.81 Cr.316.98 Cr.289.70 Cr.
Good Will0000
Treasury Stock-4.87 Cr.-2.82 Cr.1.15 Cr.6.64 Cr.
Other Assets513.21 Cr.481.64 Cr.469.15 Cr.515.31 Cr.
Cash405.18 Cr.104.81 Cr.98.77 Cr.201.10 Cr.
Current Liabilities1332.47 Cr.1021.95 Cr.1454.31 Cr.1599.86 Cr.
Long Term Asset Charges103.12 Cr.110.48 Cr.62.22 Cr.103.72 Cr.
Short Long Term Debt2.40 Lakhs15.30 Lakhs40.60 Lakhs40.60 Lakhs
Other Stockholder Equity-4.87 Cr.-2.82 Cr.1.15 Cr.6.64 Cr.
Property Plant Equipment354.12 Cr.827.08 Cr.1367.09 Cr.1173.02 Cr.
Total Cur. Assets2202.65 Cr.1774.88 Cr.2009.46 Cr.2186.40 Cr.
Long Term Investments005.50 Lakhs5.50 Lakhs
Net Tangible Assets1455.71 Cr.1770.97 Cr.2074.28 Cr.1984.64 Cr.
Short Term Investments732.01 Cr.957.01 Cr.1049.01 Cr.1069.01 Cr.
Net Receivables241 Cr.130.41 Cr.210 Cr.204.22 Cr.
Long Term Debt02.40 Lakhs17.70 Lakhs58.30 Lakhs
Inventory546.69 Cr.483.03 Cr.486.49 Cr.500.18 Cr.
Accounts Payable464.47 Cr.357.06 Cr.405.81 Cr.505.85 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account